Aesthetic Medicine Market Size By Type (Surgical Procedures, Non-surgical Procedures) By Product (Energy-based {Laser-based Aesthetic Device, Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device}, Non Energy-based {Botulinum Toxin, Dermal Fillers, Implants [Facial Implants, Breast Implants]}), By Gender (Male {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}, Female {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}), By End-use (Hospitals, Ambulatory Surgical Centres, Beauty Centres & Medical Spas, Dermatology Clinics, Home Settings), COVID19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027

Published Date: May 2021  |  Report ID: GMI2687  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 200   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

Aesthetic Medicine Market size was valued at USD 14.5 billion in 2020 and is expected to witness more than 9.2% CAGR from 2021 to 2027. Growing awareness amongst healthcare professionals and patients regarding the benefits of aesthetic medicine has positively impacted market growth. Advancements in surgical and non-surgical aesthetic procedures will also act as a primary driver for the market expansion. Increasing urge to look young and fit has boosted the demand for aesthetic treatment in developing countries. Aesthetic procedures such as liposuction, nose reshaping, and botulinum toxin injections, that add aesthetic value with minimal invasion, are gaining consumer interest in countries such as India and South Korea. Moreover, collaborative strategies of companies for research and development and rising awareness among population regarding aesthetic medicine will further impel the market progression.
 

Aesthetic Medicine Market Overview
Get more details on this report - Request Free Sample PDF
 

Aesthetic medicine mainly focuses on altering cosmetic appearance of the person as per his/her desire. It is widely conducted to treat conditions such as scars, excess fat, skin discoloration, skin laxity, moles and wrinkles among others. Aesthetic medicine uses wide range of invasive, minimally invasive and non-invasive cosmetic procedures.
 

Increasing awareness and demand for minimally invasive surgeries will stimulate the aesthetic medicine market demand during the forecast period. Owing to benefits such as reduced risk of infection and relatively less time-consumption with better outcomes are the factors that foster the patient preference for these procedures. Furthermore, technological advancements in the market offer effective solutions for such minimally invasive procedures. With continuous developments in the technology towards non-invasive and minimally invasive technology, the market is anticipated to foresee unprecedented growth during the forecast timeframe. However, due to COVID-19 pandemic, to restrict the spread of this contagious disease, government imposed strict lockdown and halt on non-emergency medical procedures. Thus, the aesthetic medicine market has experienced moderate effect of coronavirus outbreak and will observe gradual recovery with declining prevalence of COVID-19.

Growing emphasis on body aesthetics will spur industry expansion

The aesthetic medicine market is poised to foresee unprecedented growth with high adoption of advanced technologies to cater to growing customer needs. With change in lifestyle and increasing consumption of alcohol, smoking and reduced physical activities, the population is suffering from various disorders including obesity. In addition, there is rising body image consciousness among the young population. These factors considerably fuel the demand for body contouring and skin tightening procedures. Along with awareness, supportive government initiatives and funding research in the field will stimulate the market revenue.
 

Growing preference for minimally invasive and non-invasive cosmetic procedures will propel the aesthetic medicine market value

Aesthetic Medicine Market Value

Get more details on this report - Request Free Sample PDF
 

Non-surgical segment dominated more than 63% of the market share in 2020. With increasing introduction of devices for non-surgical aesthetics and population awareness regarding minimally invasive techniques will augment the growth of non-surgical procedures. Innovations in non-invasive procedure technology, thereby focusing on lesser procedure time and faster recovery are further affecting procedure adoption.
 

Non-surgical procedures include facial injectables and, cryolipolysis among others. Such procedures assist in correcting facial lines, wrinkles, cellulite reduction and reduction of unwanted fat within short time period and with minimal side effects. Additionally, a considerable increase in desire to overcome the signs of aging has been observed over the past few years. Thus, acceptance of non-surgical anti-aging procedures with expanding baby boomer population base will boost the segment growth during the forecast timeline.
 

Increasing usage of dermal fillers and botulinum toxin for enhancing facial aesthetics will impel the industry progression

Non energy-based segment in the aesthetic medicine market accounted for USD 11 billion in 2020 led by high demand for wide range of non-surgical procedures.
 

Growing disposable income in emerging economies has resulted in adoption of advanced aesthetic medicines. Dermal fillers, being one of the most commonly adopted non-energy-based procedures are used to give volume and fullness to an individual's skin. Additionally, growing demand for facial aesthetics, cost-effectivity and surge in ageing population will further escalate the demand for dermal fillers.
 

Rising acceptance of aesthetic procedures among elderly female population will simulate the market demand

Female segment dominated the aesthetic medicine market share of around 79% in 2020 led by increasing usage of facial surgeries such as rhinoplasty, blepharoplasty and breast augmentation procedures.
 

As per the American Society for Aesthetic Plastic Surgery, about 185,957 breast augmentation surgeries were performed globally in 2020. Increasing acceptance of breast augmentation procedures in females between 22-40 years of age will foster the demand for breast aesthetics thereby fuelling the industry revenue.
 

Infrastructure development in hospitals, driving patient preference for numerous aesthetic procedures will simulate the industry value

Hospitals segment in the aesthetic medicine market exceeded USD 4 billion in 2020. Increasing number of surgeries worldwide and rising expenditure on healthcare infrastructure in emerging economies has resulted in adoption of advanced aesthetic procedures.
 

Requirement of skilled professionals to perform aesthetic procedures, high cost associated with the aesthetic devices and availability of well-developed healthcare facilities will increase the number of procedures in hospitals. Moreover, growing demand for liposuction an abdominoplasty surgery, requiring sophisticated infrastructure and expertise will drive the segment expansion.
 

Increasing spending on cosmetic procedures in the U.S. will create substantial opportunities for North America region

 North America aesthetic medicine market captured more than 51% of revenue share in 2020. Growing expenditure on cosmetic and rejuvenation procedures for enhancing aesthetics is growing rapidly among the Americans.
 

There are several leading players focusing on the U.S. market. These firms are emphasizing product innovation collaborations that significantly contribute to the market size. Due to greater awareness and usage of innovative technologies in the U.S., market leaders showcase momentous growth potential. Furthermore, rising prevalence of obesity in the region owing to high acceptance of sedentary lifestyle will serve to be high impact rendering factor in the aesthetic medicine market growth.
 

Prominent industry participants are extensively focusing on product innovation and collaborations to sustain their competitive advantage

Some of the leading companies operating in the aesthetic medicine market include Allergan, Galderma, Syneron Candela, Lumenis, Merz Pharmaceuticals and Cynosure among others. These industry players are adopting various organic as well as inorganic growth strategies to obtain competitive advantage and strengthen their market position.
 

Some of the recent industry developments:

  • In September 2020, Allergan Aesthetics, part of AbbVie and Skinbetter Science announced the launch of DREAM: Driving Racial Equity in Aesthetic Medicine initiative. This strategy has resulted into expansion of resource availability to enhance patient care for broad spectrum of skin types.
     
  • In March 2020, Galderma announced the investment in aesthetic portfolio including expansion of U.S. salesforce and digital advancements in ASPIRE Galderma Rewards. Such investments have strengthened its position in the aesthetics market.
     

The aesthetic medicine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:
 

Market, By Type

  • Surgical
  • Non-surgical

Market, By Product

  • Energy-based
    • Laser-based Aesthetic Device
    • Radiofrequency (RF)-based Aesthetic Device
    • Light-based Aesthetic Device
    • Ultrasound Aesthetic Device
    • Others
  • Non Energy-based
    • Botulinum Toxin
    • Dermal Fillers
    • Implants
      • Facial Implants
      • Breast Implants
      • Others
    • Others

Market, By Gender

  • Male
    • 18 years and below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years and above
  • Female
    • 18 years and below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years and above

Market, By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Beauty centers and medical spas
  • Dermatology clinics
  • Home settings

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
       

Frequently Asked Questions (FAQ) :

Aesthetic medicine market size was valued at USD 14.5 billion in 2020 and will witness a CAGR of over 9.2% through 2027 with rising awareness of its benefits among healthcare professionals and patients.
Non-surgical segment had held a market share of more than 63% in 2020 owing to the development of novel devices for non-surgical aesthetics and growing awareness about minimally invasive techniques among people.
Female segment accounted for a market share of around 79% in 2020 and will increase due to increasing adoption of facial surgeries such as rhinoplasty, blepharoplasty and breast augmentation procedures.
Hospitals recorded a valuation of more than USD 4 billion in 2020 and will grow with increasing adoption of advanced aesthetic procedures driven by growing number of surgeries and rising expenditure on healthcare infrastructure in developing economies.
North America aesthetic medicine market held more than 51% revenue share in 2020 and will grow on account of rising expenditure on cosmetic and rejuvenation procedures for enhancing aesthetics in the region.

Premium Report Details

  • Published Date: May 2021
  • Pages: 200
  • Tables: 230
  • Charts / Figures: 11
  • Companies covered: 11
  • Countries covered: 16

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X